Long term molecular responses in a cohort of Danish patients with essential thrombocythemia, polycythemia vera and myelofibrosis treated with recombinant interferon alpha-Reference-Cited by-同舟云学术

Long term molecular responses in a cohort of Danish patients with essential thrombocythemia, polycythemia vera and myelofibrosis treated with recombinant interferon alpha

Published:2013-09 Issue:9 Volume:37 Page:1041-1045
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Stauffer Larsen Thomas,Iversen Katrine F.,Hansen Esben,Mathiasen Anders Bruun,Marcher Claus,Frederiksen Mikael,Larsen Herdis,Helleberg Inge,Riley Caroline Hasselbalch,Bjerrum Ole W.,Rønnov-Jessen Dorthe,Møller Michael Boe,de Stricker Karin,Vestergaard Hanne,Hasselbalch Hans Carl

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference27 articles.

1. The JAK2 V617F allele burden in essential thrombocythemia, polycythemia vera and primary myelofibrosis – impact on disease phenotype;Larsen;Eur J Haematol,2007

2. Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera;Kiladjian;Blood,2008

3. Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conference;Barosi;Blood,2009

4. High molecular response rate of polycythemia vera patients treated with pegylated interferon alpha-2a;Kiladjian;Blood,2006

5. Pegylated interferon alfa-2a yields high rates of hematologic and molecular response in patients with advanced essential thrombocythemia and polycythemia vera;Quintas-Cardama;J Clin Oncol,2009

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Moving toward disease modification in polycythemia vera;Blood;2023-11-30

2. Mutations, inflammation and phenotype of myeloproliferative neoplasms;Frontiers in Oncology;2023-05-22

3. An alternative dosing strategy for ropeginterferon alfa-2b may help improve outcomes in myeloproliferative neoplasms: An overview of previous and ongoing studies with perspectives on the future;Frontiers in Oncology;2023-01-19

4. Recombinant Interferon-β in the Treatment of Polycythemia Vera and Related Neoplasms: Rationales and Perspectives;Cancers;2022-11-09

5. Cytokines, Interferons, and Hematopoietic Growth Factors;Holland‐Frei Cancer Medicine;2022-10-21